GEHC – GE HealthCare Technologies Inc

GEHC — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.43

Margin Of Safety %

Put/Call OI Ratio

0.65

EPS Next Q Diff

-0.27

EPS Last/This Y

0.5

EPS This/Next Y

0.51

Price

69.75

Target Price

92.71

Analyst Recom

1.71

Performance Q

-18

Upside

43.6%

Beta

1.31

Ticker: GEHC

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	GEHC	75.62	0.66	1.94	45268
2026-03-10	GEHC	72.73	0.67	0.80	46274
2026-03-11	GEHC	72.64	0.67	0.73	46428
2026-03-12	GEHC	70.36	0.65	4.21	46265
2026-03-13	GEHC	70.33	0.65	4.19	46265
2026-03-17	GEHC	72.34	0.69	0.20	47757
2026-03-18	GEHC	70.23	0.67	4.48	48462
2026-03-19	GEHC	70.36	0.68	0.44	48595
2026-03-20	GEHC	69.66	0.67	1.24	48664
2026-03-23	GEHC	71.65	0.74	1.02	40374
2026-03-24	GEHC	70.99	0.71	0.98	42420
2026-03-25	GEHC	72.22	0.71	0.15	42652
2026-03-26	GEHC	71.56	0.70	0.92	42926
2026-03-27	GEHC	69.21	0.71	2.40	43229
2026-03-30	GEHC	68.76	0.68	0.87	41768
2026-03-31	GEHC	71.18	0.68	0.12	42203
2026-04-01	GEHC	71.98	0.67	2.02	42898
2026-04-02	GEHC	70.37	0.67	0.13	43117
2026-04-06	GEHC	70.4	0.64	5.73	43922
2026-04-07	GEHC	69.72	0.65	3.31	44271
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	GEHC	75.63	5.0	171.4	5.06
2026-03-10	GEHC	72.74	5.0	11.1	5.06
2026-03-11	GEHC	72.62	5.0	115.4	5.06
2026-03-12	GEHC	70.33	3.8	29.6	5.06
2026-03-13	GEHC	70.79	3.8	138.0	5.06
2026-03-17	GEHC	72.34	3.8	126.3	5.06
2026-03-18	GEHC	70.24	3.8	37.8	5.06
2026-03-19	GEHC	70.36	3.8	280.3	5.06
2026-03-20	GEHC	69.65	3.8	245.5	5.06
2026-03-23	GEHC	71.61	3.8	358.5	5.06
2026-03-24	GEHC	70.96	3.8	247.6	5.06
2026-03-25	GEHC	72.20	3.7	327.4	5.06
2026-03-26	GEHC	71.56	3.7	249.8	5.06
2026-03-27	GEHC	69.23	3.7	180.8	5.06
2026-03-30	GEHC	68.77	3.7	256.4	5.06
2026-03-31	GEHC	71.15	3.7	377.3	5.06
2026-04-01	GEHC	71.96	3.7	308.4	5.06
2026-04-02	GEHC	70.35	3.7	209.0	5.06
2026-04-06	GEHC	70.40	3.7	278.1	5.06
2026-04-07	GEHC	69.75	3.7	248.9	5.06
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	GEHC	0.00	4.87	2.20
2026-03-10	GEHC	0.00	4.87	2.20
2026-03-11	GEHC	0.00	4.87	2.40
2026-03-12	GEHC	0.00	4.87	2.40
2026-03-13	GEHC	0.00	4.87	2.40
2026-03-17	GEHC	0.00	4.89	2.40
2026-03-18	GEHC	0.00	4.89	2.40
2026-03-19	GEHC	0.00	4.89	2.40
2026-03-20	GEHC	0.00	4.89	2.40
2026-03-23	GEHC	0.00	4.90	2.40
2026-03-24	GEHC	0.00	4.90	2.40
2026-03-25	GEHC	0.00	4.90	2.43
2026-03-26	GEHC	0.00	4.90	2.43
2026-03-27	GEHC	0.00	4.90	2.43
2026-03-30	GEHC	0.00	4.85	2.43
2026-03-31	GEHC	0.00	4.85	2.43
2026-04-01	GEHC	0.00	4.85	2.43
2026-04-02	GEHC	0.00	4.85	2.43
2026-04-06	GEHC	0.00	5.81	2.43
2026-04-07	GEHC	0.00	5.81	2.43
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

1.44

Avg. EPS Est. Current Quarter

1.05

Avg. EPS Est. Next Quarter

1.17

Insider Transactions

Institutional Transactions

5.81

Beta

1.31

Average Sales Estimate Current Quarter

5026

Average Sales Estimate Next Quarter

5254

Fair Value

92.16

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

26.4

Max Drawdown 5-Year %

Target Price

92.71

P/E

15.31

Forward P/E

12.46

PEG

1.16

P/S

1.54

P/B

3.06

P/Free Cash Flow

21.12

EPS

4.55

Average EPS Est. Cur. Y

5.06

EPS Next Y. (Est.)

5.57

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.11

Relative Volume

0.88

Return on Equity vs Sector %

-7.4

Return on Equity vs Industry %

8.3

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

248.9

◆ GEHC Healthcare

$69.73

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

13/25

Volume

7/15

Valuation

18/20

TP/AR

1/10

Options

5/10

RSI

39.2

Range 1M

17.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

11/30

Estimates

6/20

Inst/Vol

6/15

Options

5/10

EPS Yr

10.2%

EPS NY

10.7%

52W%

37.6%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🟢 BUY +54.1% upside

Quality

15/30

Valuation

19/30

Growth

8/25

Stability

6/10

LT Trend

3/5

Upside

+54.1%

Quality

MoS

32%

GE HealthCare Technologies Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 54000

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

GEHC

Latest News

—

Caricamento notizie per GEHC…

stock quote shares GEHC – GE HealthCare Technologies Inc Stock Price stock today

news today GEHC – GE HealthCare Technologies Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch GEHC – GE HealthCare Technologies Inc yahoo finance google finance

stock history GEHC – GE HealthCare Technologies Inc invest stock market

stock prices GEHC premarket after hours

ticker GEHC fair value insiders trading

QDEL – QuidelOrtho Corporation

QDEL — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

16.32

Margin Of Safety %

Put/Call OI Ratio

0.61

EPS Next Q Diff

-0.34

EPS Last/This Y

18.86

EPS This/Next Y

0.81

Price

14.98

Target Price

33.14

Analyst Recom

2.67

Performance Q

-50.17

Upside

-3,992.5%

Beta

0.99

Ticker: QDEL

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	QDEL	19.85	0.34	2.48	6940
2026-03-10	QDEL	19.3	0.36	0.62	7120
2026-03-11	QDEL	18.04	0.37	0.22	7376
2026-03-12	QDEL	17.91	0.37	0.29	7539
2026-03-13	QDEL	17.92	0.37	0.29	7539
2026-03-17	QDEL	19.13	0.36	2.34	7758
2026-03-18	QDEL	17.09	0.44	1.45	8421
2026-03-19	QDEL	16.58	0.43	1.21	8452
2026-03-20	QDEL	15.23	0.44	0.25	8749
2026-03-23	QDEL	16.54	0.46	0.38	7898
2026-03-24	QDEL	16.17	0.45	0.22	8045
2026-03-25	QDEL	16.09	0.45	1.45	8044
2026-03-26	QDEL	15.59	0.48	0.31	8272
2026-03-27	QDEL	14.8	0.47	1.74	8344
2026-03-30	QDEL	15.26	0.58	0.16	9040
2026-03-31	QDEL	16.43	0.58	10.20	9046
2026-04-01	QDEL	16.56	0.59	0.00	9155
2026-04-02	QDEL	17.19	0.59	2.42	9204
2026-04-06	QDEL	15.82	0.59	4.48	9233
2026-04-07	QDEL	14.96	0.61	2.75	9386
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	QDEL	19.85	-36.4	1357.9	2.17
2026-03-10	QDEL	19.28	-36.4	1360.9	2.17
2026-03-11	QDEL	18.04	-36.4	1355.6	2.17
2026-03-12	QDEL	17.93	-36.4	1364.4	2.17
2026-03-13	QDEL	17.09	-36.4	1358.7	2.17
2026-03-17	QDEL	19.12	-36.4	1376.5	2.17
2026-03-18	QDEL	17.11	-36.4	1349.9	2.17
2026-03-19	QDEL	16.59	-36.4	1281.3	2.17
2026-03-20	QDEL	15.24	-36.4	1272.7	2.17
2026-03-23	QDEL	16.54	-36.4	1280.9	2.17
2026-03-24	QDEL	16.19	-36.4	1278.7	2.17
2026-03-25	QDEL	16.03	-36.4	1277.7	2.17
2026-03-26	QDEL	15.58	-36.4	1274.7	2.17
2026-03-27	QDEL	14.78	-36.4	1269.7	2.17
2026-03-30	QDEL	15.28	-36.4	1272.8	2.17
2026-03-31	QDEL	16.43	-36.4	1280.2	2.17
2026-04-01	QDEL	16.58	-36.4	1281.2	2.17
2026-04-02	QDEL	17.19	-36.4	1285.1	2.17
2026-04-06	QDEL	15.87	-36.4	1276.7	2.17
2026-04-07	QDEL	14.98	-36.4	1279.3	2.17
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	QDEL	7.64	1.60	15.11
2026-03-10	QDEL	7.64	1.60	15.11
2026-03-11	QDEL	7.64	1.60	15.29
2026-03-12	QDEL	7.64	1.60	15.29
2026-03-13	QDEL	7.64	1.60	15.29
2026-03-17	QDEL	7.64	1.87	15.29
2026-03-18	QDEL	7.64	1.87	15.29
2026-03-19	QDEL	7.64	1.87	15.29
2026-03-20	QDEL	7.64	1.87	15.29
2026-03-23	QDEL	7.64	1.87	15.29
2026-03-24	QDEL	7.64	1.87	15.29
2026-03-25	QDEL	7.64	1.87	16.32
2026-03-26	QDEL	7.64	1.87	16.32
2026-03-27	QDEL	7.64	1.87	16.32
2026-03-30	QDEL	7.64	1.87	16.32
2026-03-31	QDEL	7.64	1.87	16.32
2026-04-01	QDEL	7.64	1.87	16.32
2026-04-02	QDEL	7.64	1.87	16.32
2026-04-06	QDEL	7.64	1.87	16.32
2026-04-07	QDEL	7.64	1.87	16.32
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.46

Avg. EPS Est. Current Quarter

0.47

Avg. EPS Est. Next Quarter

0.12

Insider Transactions

7.64

Institutional Transactions

1.87

Beta

0.99

Average Sales Estimate Current Quarter

682

Average Sales Estimate Next Quarter

630

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.7

Max Drawdown 5-Year %

-91.5

Target Price

33.14

P/E

Forward P/E

5.15

PEG

0.29

P/S

0.37

P/B

0.53

P/Free Cash Flow

EPS

-16.66

Average EPS Est. Cur. Y

2.17

EPS Next Y. (Est.)

2.98

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-41.42

Relative Volume

1.24

Return on Equity vs Sector %

-86.4

Return on Equity vs Industry %

-70.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.29

EBIT Estimation

1279.3

◆ QDEL Healthcare

$14.98

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

4/15

Valuation

17/20

TP/AR

0/10

Options

3/10

RSI

Range 1M

12.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

13/30

Estimates

0/20

Inst/Vol

5/15

Options

2/10

EPS Yr

1.2%

EPS NY

35.5%

52W%

2.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +460.6% upside

Quality

4/30

Valuation

22/30

Growth

13/25

Stability

5/10

LT Trend

4/5

Upside

+460.6%

Quality

QuidelOrtho Corporation

Sector: Healthcare

Industry: Medical Devices

Employees: 6500

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

QDEL

Latest News

—

Caricamento notizie per QDEL…

stock quote shares QDEL – QuidelOrtho Corporation Stock Price stock today

news today QDEL – QuidelOrtho Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch QDEL – QuidelOrtho Corporation yahoo finance google finance

stock history QDEL – QuidelOrtho Corporation invest stock market

stock prices QDEL premarket after hours

ticker QDEL fair value insiders trading

INGN – Inogen Inc.

INGN — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

4.86

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

0.23

EPS Last/This Y

0.34

EPS This/Next Y

0.21

Price

6.81

Target Price

12.67

Analyst Recom

Performance Q

2.26

Upside

-542.6%

Beta

1.63

Ticker: INGN

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	INGN	6.36	0.12	0.00	1033
2026-03-10	INGN	6.23	0.12	0.00	1015
2026-03-11	INGN	6.22	0.12	0.00	1017
2026-03-12	INGN	6.11	0.12	0.00	1017
2026-03-13	INGN	6.1	0.12	0.00	1017
2026-03-17	INGN	6.2	0.12	0.00	1015
2026-03-18	INGN	6.12	0.12	0.00	1015
2026-03-19	INGN	6.14	0.10	0.00	1062
2026-03-20	INGN	6.09	0.09	0.00	1056
2026-03-23	INGN	6.44	0.06	0.69	603
2026-03-24	INGN	6.33	0.06	0.69	603
2026-03-25	INGN	6.41	0.08	0.00	609
2026-03-26	INGN	6.49	0.08	0.00	609
2026-03-27	INGN	6.19	0.08	0.00	613
2026-03-30	INGN	6.12	0.08	0.07	614
2026-03-31	INGN	6.18	0.08	0.07	614
2026-04-01	INGN	6.26	0.08	0.00	638
2026-04-02	INGN	6.22	0.08	0.00	638
2026-04-06	INGN	6.49	0.08	0.30	638
2026-04-07	INGN	6.81	0.08	0.30	638
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	INGN	6.37	-90.9	-	-0.52
2026-03-10	INGN	6.24	-90.9	-	-0.52
2026-03-11	INGN	6.23	-90.9	-	-0.52
2026-03-12	INGN	6.11	-90.9	-	-0.52
2026-03-13	INGN	6.07	-90.9	-	-0.52
2026-03-17	INGN	6.20	-90.9	-	-0.52
2026-03-18	INGN	6.13	-90.9	-	-0.52
2026-03-19	INGN	6.14	-90.9	-	-0.52
2026-03-20	INGN	6.10	-90.9	-	-0.52
2026-03-23	INGN	6.44	-90.9	-	-0.52
2026-03-24	INGN	6.32	-90.9	-	-0.52
2026-03-25	INGN	6.43	-90.9	-	-0.52
2026-03-26	INGN	6.50	-90.9	-	-0.52
2026-03-27	INGN	6.19	-90.9	-	-0.52
2026-03-30	INGN	6.11	-90.9	-	-0.52
2026-03-31	INGN	6.19	-90.9	-	-0.52
2026-04-01	INGN	6.26	-90.9	-	-0.52
2026-04-02	INGN	6.20	-90.9	-	-0.52
2026-04-06	INGN	6.37	-90.9	-	-0.52
2026-04-07	INGN	6.81	-90.9	-	-0.52
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	INGN	0.00	3.31	4.06
2026-03-10	INGN	0.00	3.31	4.06
2026-03-11	INGN	0.00	3.31	5.05
2026-03-12	INGN	0.00	3.31	5.05
2026-03-13	INGN	0.00	3.31	5.05
2026-03-17	INGN	0.00	3.47	5.05
2026-03-18	INGN	0.00	3.47	5.05
2026-03-19	INGN	0.00	3.47	5.05
2026-03-20	INGN	0.00	3.47	5.05
2026-03-23	INGN	0.00	3.49	5.05
2026-03-24	INGN	0.00	3.49	5.05
2026-03-25	INGN	0.00	3.49	4.86
2026-03-26	INGN	0.00	3.49	4.86
2026-03-27	INGN	0.00	3.49	4.86
2026-03-30	INGN	0.00	3.49	4.86
2026-03-31	INGN	0.00	3.49	4.86
2026-04-01	INGN	0.00	3.49	4.86
2026-04-02	INGN	0.00	3.49	4.86
2026-04-06	INGN	0.00	3.55	4.86
2026-04-07	INGN	0.00	3.55	4.86
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.26

Avg. EPS Est. Current Quarter

-0.21

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

Institutional Transactions

3.55

Beta

1.63

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

91.7

Max Drawdown 5-Year %

-94.9

Target Price

12.67

P/E

Forward P/E

PEG

P/S

0.53

P/B

0.96

P/Free Cash Flow

EPS

-0.86

Average EPS Est. Cur. Y

-0.52

EPS Next Y. (Est.)

-0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.52

Relative Volume

2.24

Return on Equity vs Sector %

-39.3

Return on Equity vs Industry %

-23.7

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.36

EBIT Estimation

◆ INGN Healthcare

$6.80

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

6/25

Volume

3/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

64.6

Range 1M

96.8%

Sup Dist

9.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

10/25

Growth

21/30

Estimates

0/20

Inst/Vol

8/15

Options

10/10

EPS Yr

9.3%

EPS NY

37.6%

52W%

37.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +86.3% upside

Quality

5/30

Valuation

16/30

Growth

14/25

Stability

8/10

LT Trend

2/5

Upside

+86.3%

Quality

Inogen, Inc

Sector: Healthcare

Industry: Medical Devices

Employees: 753

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.

INGN

Latest News

—

Caricamento notizie per INGN…

stock quote shares INGN – Inogen Inc. Stock Price stock today

news today INGN – Inogen Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch INGN – Inogen Inc. yahoo finance google finance

stock history INGN – Inogen Inc. invest stock market

stock prices INGN premarket after hours

ticker INGN fair value insiders trading

XAIR – Beyond Air Inc

XAIR — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

1.15

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

9.75

EPS This/Next Y

2.39

Price

0.71

Target Price

7.75

Analyst Recom

1.4

Performance Q

-13.76

Upside

-26,818.3%

Beta

0.48

Ticker: XAIR

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	XAIR	0.8519	N/A	N/A	0
2026-03-10	XAIR	0.8104	N/A	N/A	0
2026-03-11	XAIR	0.8024	N/A	N/A	0
2026-03-12	XAIR	0.8102	N/A	N/A	0
2026-03-13	XAIR	0.8102	N/A	N/A	0
2026-03-17	XAIR	0.8054	N/A	N/A	0
2026-03-18	XAIR	0.793	N/A	N/A	0
2026-03-20	XAIR	0.781	N/A	N/A	0
2026-03-25	XAIR	0.7317	N/A	N/A	0
2026-03-26	XAIR	0.69	N/A	N/A	0
2026-03-27	XAIR	0.7166	N/A	N/A	0
2026-03-30	XAIR	0.6759	N/A	N/A	0
2026-03-31	XAIR	0.6944	N/A	N/A	0
2026-04-01	XAIR	0.705	N/A	N/A	0
2026-04-06	XAIR	0.7001	N/A	N/A	0
2026-04-07	XAIR	0.7132	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	XAIR	0.85	-	-	-4.05
2026-03-10	XAIR	0.82	-	-	-4.05
2026-03-11	XAIR	0.80	-	-	-4.05
2026-03-12	XAIR	0.81	-	-	-4.05
2026-03-13	XAIR	0.82	-	-	-4.05
2026-03-17	XAIR	0.81	-	-	-4.05
2026-03-18	XAIR	0.78	-	-	-4.05
2026-03-19	XAIR	0.78	-	-	-4.05
2026-03-20	XAIR	0.78	-	-	-4.05
2026-03-23	XAIR	0.80	-	-	-4.05
2026-03-24	XAIR	0.75	-	-	-4.05
2026-03-25	XAIR	0.74	-	-	-4.05
2026-03-26	XAIR	0.69	-	-	-4.05
2026-03-27	XAIR	0.72	-	-	-4.05
2026-03-30	XAIR	0.67	-	-	-4.05
2026-03-31	XAIR	0.69	-	-	-4.05
2026-04-01	XAIR	0.71	-	-	-4.05
2026-04-02	XAIR	0.69	-	-	-4.05
2026-04-06	XAIR	0.69	-	-	-4.05
2026-04-07	XAIR	0.71	-	-	-4.05
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	XAIR	0.00	-1.13	7.44
2026-03-10	XAIR	0.00	-1.13	7.44
2026-03-11	XAIR	0.00	-1.13	1.56
2026-03-12	XAIR	0.00	-1.13	1.56
2026-03-13	XAIR	0.00	-1.13	1.56
2026-03-18	XAIR	0.00	-1.13	1.56
2026-03-19	XAIR	0.00	-1.13	1.56
2026-03-20	XAIR	0.00	-1.13	1.56
2026-03-23	XAIR	0.00	-1.13	1.56
2026-03-24	XAIR	0.00	-1.13	1.56
2026-03-25	XAIR	0.00	-1.13	1.15
2026-03-26	XAIR	0.00	-1.13	1.15
2026-03-27	XAIR	0.00	-1.13	1.15
2026-03-30	XAIR	0.00	-1.13	1.15
2026-03-31	XAIR	0.00	-1.13	1.15
2026-04-01	XAIR	0.00	-1.13	1.15
2026-04-02	XAIR	0.00	-1.13	1.15
2026-04-06	XAIR	0.00	-1.13	1.15
2026-04-07	XAIR	0.00	-1.13	1.15
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

-0.45

Avg. EPS Est. Next Quarter

-0.48

Insider Transactions

Institutional Transactions

-1.13

Beta

0.48

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.8

Max Drawdown 5-Year %

-99.8

Target Price

7.75

P/E

Forward P/E

PEG

P/S

1.08

P/B

0.74

P/Free Cash Flow

EPS

-5.42

Average EPS Est. Cur. Y

-4.05

EPS Next Y. (Est.)

-1.66

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-447.75

Relative Volume

0.01

Return on Equity vs Sector %

-409.7

Return on Equity vs Industry %

-394

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ XAIR Healthcare

$0.71

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

20/25

Volume

11/15

Valuation

12/20

TP/AR

2/10

Options

0/10

RSI

36.7

Range 1M

26.2%

Sup Dist

3.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

25/30

Estimates

0/20

Inst/Vol

0/15

Options

0/10

EPS Yr

72.2%

EPS NY

54.5%

52W%

1.2%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +991.5% upside

Quality

2/30

Valuation

16/30

Growth

17/25

Stability

3/10

LT Trend

1/5

Upside

+991.5%

Quality

Beyond Air, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 61

Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.

XAIR

Latest News

—

Caricamento notizie per XAIR…

stock quote shares XAIR – Beyond Air Inc Stock Price stock today

news today XAIR – Beyond Air Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch XAIR – Beyond Air Inc yahoo finance google finance

stock history XAIR – Beyond Air Inc invest stock market

stock prices XAIR premarket after hours

ticker XAIR fair value insiders trading

OPGN – Opgen Inc

OPGN — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

1.02

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

24.75

Target Price

Analyst Recom

Performance Q

-57.39

Upside

N/A

Beta

-0.64

Ticker: OPGN

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	OPGN	24.75	N/A	N/A	0
2026-03-10	OPGN	24.75	N/A	N/A	0
2026-03-11	OPGN	24.75	N/A	N/A	0
2026-03-12	OPGN	24.75	N/A	N/A	0
2026-03-13	OPGN	24.75	N/A	N/A	0
2026-03-17	OPGN	24.75	N/A	N/A	0
2026-03-18	OPGN	24.75	N/A	N/A	0
2026-03-20	OPGN	24.75	N/A	N/A	0
2026-03-25	OPGN	24.75	N/A	N/A	0
2026-03-26	OPGN	24.75	N/A	N/A	0
2026-03-27	OPGN	24.75	N/A	N/A	0
2026-03-30	OPGN	24.75	N/A	N/A	0
2026-03-31	OPGN	24.75	N/A	N/A	0
2026-04-01	OPGN	24.75	N/A	N/A	0
2026-04-06	OPGN	24.75	N/A	N/A	0
2026-04-07	OPGN	24.75	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

5 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	OPGN	24.75	-	-	-
2026-03-10	OPGN	24.75	-	-	-
2026-03-11	OPGN	24.75	-	-	-
2026-03-12	OPGN	24.75	-	-	-
2026-03-13	OPGN	24.75	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

5 items 1 of 1

Last Quarter Act. EPS

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

-0.64

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

100

Growth Score

Sentiment Score

Actual DrawDown %

27.2

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

6.13

P/B

P/Free Cash Flow

EPS

-40.32

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

54.6

Return on Equity vs Industry %

52.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for OPGN

OpGen, Inc.

Sector: Financial Services

Industry: Capital Markets

Employees: 1

CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.

OPGN

Latest News

—

Caricamento notizie per OPGN…

stock quote shares OPGN – Opgen Inc Stock Price stock today

news today OPGN – Opgen Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch OPGN – Opgen Inc yahoo finance google finance

stock history OPGN – Opgen Inc invest stock market

stock prices OPGN premarket after hours

ticker OPGN fair value insiders trading

OFIX – Orthofix Medical Inc

OFIX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

2.73

Margin Of Safety %

Put/Call OI Ratio

63.47

EPS Next Q Diff

0.06

EPS Last/This Y

2.48

EPS This/Next Y

0.71

Price

11.74

Target Price

17.25

Analyst Recom

1.8

Performance Q

-23.61

Upside

-799.4%

Beta

0.82

Ticker: OFIX

16 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	OFIX	12.47	0.16	0.00	22
2026-03-10	OFIX	12.38	0.16	0.00	22
2026-03-11	OFIX	12.29	0.16	999.99	22
2026-03-12	OFIX	12.03	63.32	999.99	1222
2026-03-13	OFIX	12.03	63.32	999.99	1222
2026-03-17	OFIX	12.01	63.37	999.99	1223
2026-03-18	OFIX	11.85	63.37	999.99	1223
2026-03-20	OFIX	11.65	63.37	999.99	1223
2026-03-25	OFIX	11.94	66.89	2.00	1222
2026-03-26	OFIX	11.8	66.89	2.00	1222
2026-03-27	OFIX	11.5	66.89	2.00	1222
2026-03-30	OFIX	11.32	66.89	2.00	1222
2026-03-31	OFIX	11.47	66.89	2.00	1222
2026-04-01	OFIX	11.6	66.89	2.00	1222
2026-04-06	OFIX	11.79	63.47	1.00	1225
2026-04-07	OFIX	11.72	63.47	1.00	1225
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

16 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	OFIX	12.47	-809.1	-	0.15
2026-03-10	OFIX	12.39	-809.1	-	0.15
2026-03-11	OFIX	12.29	-809.1	-	0.15
2026-03-12	OFIX	12.02	-809.1	-	0.15
2026-03-13	OFIX	11.70	-809.1	-	0.15
2026-03-17	OFIX	12.00	-809.1	-	0.15
2026-03-18	OFIX	11.86	-809.1	-	0.15
2026-03-19	OFIX	11.68	-809.1	-	0.15
2026-03-20	OFIX	11.65	-809.1	-	0.15
2026-03-23	OFIX	11.86	-809.1	-	0.15
2026-03-24	OFIX	11.74	-809.1	-	0.15
2026-03-25	OFIX	11.94	-809.1	-	0.15
2026-03-26	OFIX	11.81	-809.1	-	0.15
2026-03-27	OFIX	11.50	-809.1	-	0.15
2026-03-30	OFIX	11.33	-809.1	-	0.15
2026-03-31	OFIX	11.48	-809.1	-	0.15
2026-04-01	OFIX	11.61	-809.1	-	0.15
2026-04-02	OFIX	11.53	-809.1	-	0.15
2026-04-06	OFIX	11.78	-809.1	-	0.15
2026-04-07	OFIX	11.74	-809.1	-	0.15
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	OFIX	11.56	-2.89	2.67
2026-03-10	OFIX	12.32	-2.89	2.67
2026-03-11	OFIX	12.32	-2.89	2.80
2026-03-12	OFIX	12.32	-2.89	2.80
2026-03-13	OFIX	12.32	-2.89	2.80
2026-03-18	OFIX	12.32	-3.01	2.80
2026-03-19	OFIX	11.67	-3.01	2.80
2026-03-20	OFIX	11.67	-3.01	2.80
2026-03-23	OFIX	11.67	-2.93	2.80
2026-03-24	OFIX	11.67	-2.93	2.80
2026-03-25	OFIX	11.67	-2.93	2.73
2026-03-26	OFIX	11.67	-2.93	2.73
2026-03-27	OFIX	11.67	-2.93	2.73
2026-03-30	OFIX	11.67	-2.93	2.73
2026-03-31	OFIX	11.67	-2.93	2.73
2026-04-01	OFIX	11.67	-2.93	2.73
2026-04-02	OFIX	11.67	-2.93	2.73
2026-04-06	OFIX	11.67	-2.91	2.73
2026-04-07	OFIX	11.67	-2.91	2.73
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.06

Avg. EPS Est. Current Quarter

-0.29

Avg. EPS Est. Next Quarter

Insider Transactions

11.67

Institutional Transactions

-2.91

Beta

0.82

Average Sales Estimate Current Quarter

193

Average Sales Estimate Next Quarter

212

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

74.5

Max Drawdown 5-Year %

-78.6

Target Price

17.25

P/E

Forward P/E

PEG

P/S

0.57

P/B

1.04

P/Free Cash Flow

EPS

-2.34

Average EPS Est. Cur. Y

0.15

EPS Next Y. (Est.)

0.86

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-11.21

Relative Volume

0.94

Return on Equity vs Sector %

-47.9

Return on Equity vs Industry %

-32.3

EPS 1 7Days Diff

-0.5

EPS 1 30Days Diff

-0.27

EBIT Estimation

◆ OFIX Healthcare

$11.71

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

0/20

Pullback

17/25

Volume

7/15

Valuation

14/20

TP/AR

1/10

Options

2/10

RSI

42.1

Range 1M

38.8%

Sup Dist

1.9%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

0/25

Growth

21/30

Estimates

2/20

Inst/Vol

1/15

Options

3/10

EPS Yr

43.8%

EPS NY

51.2%

52W%

21.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +125.7% upside

Quality

6/30

Valuation

20/30

Growth

16/25

Stability

7/10

LT Trend

1/5

Upside

+125.7%

Quality

Orthofix Medical Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 1605

Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

OFIX

Latest News

—

Caricamento notizie per OFIX…

stock quote shares OFIX – Orthofix Medical Inc Stock Price stock today

news today OFIX – Orthofix Medical Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch OFIX – Orthofix Medical Inc yahoo finance google finance

stock history OFIX – Orthofix Medical Inc invest stock market

stock prices OFIX premarket after hours

ticker OFIX fair value insiders trading

No more stocks to show

GEHC – GE HealthCare Technologies Inc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GEHC

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

QDEL – QuidelOrtho Corporation

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: QDEL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y